Journal of Clinical Hepatology 2014 Issue 2 Diagnosis and treatment of hepatic failure:current trends

Diagnosis and treatment of hepatic failure:current trends
Li Mengdong;,Nie Qinghe;

..............page:113-116

Liver failure related bacterial infection and antimicrobial treatment
Wang Yingjie;

..............page:117-120

Advances in prevention and treatment of hepatic encephalopathy
Zhang Xuqing;

..............page:121-124

Maintenance of internal environment homeostasis in patients with liver failure
Nie Qinghe;,Zhu Ting;

..............page:125-128

Analysis of complications and death causes of 1892 patients with liver failure
Nie Qinghe;,Zhang Ye;

..............page:129-132

Changes and clinical significance of plasma adiponectin in patients with hepatitis B virus-related a-cute-on chronic liver failure
sun wen jin ;, wang yan ;, wang li zhi ;, xiao zuo han ;

..............page:133-135

Clinical features and prognosis in 130 patients with alcoholic liver failure
chang bin xia ;, hao shu li ;, li bao sen ;, sun ying ;, zuo guang ju ;, zhang wei ;, zhao jun ;, zou zheng sheng ;

..............page:136-140

xue shu bu duan xing wei

..............page:140-140

Adefovir dipivoxil alone or in combination with lamivudine in the treatment of patients with lamivu-dine-resistant hepatitis Be antigen-positive chronic hepatitis B
Li Xiaodan;,Ren Fangyuan;

..............page:141-144

Risk factors of hepatic steatosis in male patients with chronic hepatitis B
a li ya re ha ti ;, chen lan ;, dong ping ;, fan xiao tang ;, he fang ping ;, shi xiu jiang ;, xi er na yi a bu du hei li li ;, zhang peng fei ;, zhu da ;

..............page:145-148

Efficacy and influence factors of pegylated interferon alpha-2a plus ribavirin for treatment of patients with chronic hepatitis C
fan ying ;, guan yu juan ;, hong wen zuo ;, li jian ping ;, pan neng lang ;, yang ke li ;

..............page:149-153

Etiologic changes in patients with liver cirrhosis from 2002 to 2011 in North China
chang bin xia ;, guan qun ;, li bao sen ;, li jin ;, sun ying ;, zuo guang ju ;, wang xiao xia ;, zou zheng sheng ;

..............page:154-158

Radioimmunoimaging of 99mTc labelled humanized single-chain Fv dimers and immunonanoparticles for hepatocellular carcinoma in nude mice
bie cai qun ;, fan hong mei ;, li meng ;, liang xu jing ;, sun shi min ;, tang shao hui ;

..............page:159-162

Effects of pentoxifylline on ethanol metabolic enzymes and peroxisome proliferator-activated receptor alpha in mice with alcoholic liver disease
dong lei ;, liu ya ping ;, qin bin ;, qu yao ning ;, shi hai tao ;

..............page:163-167

Tolerance of concanavalin A in three different strains of mice with acute hepatic injury
Sheng Guoguang;,Yu Huijie;

..............page:168-171

Changes in intestinal barrier function and protective effects of Huazhirougan granule in rats with alco-holic fatty liver disease
li xiao mei ;, liu fen ;, luo lian rong ;, song hong yun ;, sun bao cun ;, yao jing chun ;, zhao zhi quan ;

..............page:172-175

Changes of serum cytokines and pulmonary intravascular macrophages in rats with hepatopulmonary syndrome
guo yue ning ;, wang li guo ;, wang xia zhen ;, zhang zuo ;

..............page:176-179

Inhibition of proliferation of hepatoma cell line H22 cells by brucea oil in vitro and in vivo
song yan li ;, wu zuo ;, xue rui ;, zhang yu jie ;

..............page:180-183

Entecavir and matrine in the treatment of patients with chronic hepatitis B
Jiao Jian;,Liu Mei;,Ren Weixin;

..............page:184-185

Interferon-α and matrine in the treatment of patients with HbeAg-positive hepatitis B
Li Weihong;

..............page:186-187

Influence of genotypes to sustained viral response in patients with chronic hepatitis C
Meng Gang;,Wang Lizhi;,Xiao Zuohan;

..............page:188-189

Ascitic spectrum of pathogens and drug tolerance in cirrhotic patients with spontaneous bacterial peritonitis
Peng Hao;,Wang Jun;

..............page:190-191

Combination of Fufang Bijiaruangan tablet and glyeyrrhizin in the treatment of patients with compensated liver cirrhosis
Hu Cuilan;,Liu Chungang;,Yuan Yanmei;

..............page:192-193

Risk factors of early recurrence of tumor after hepalobectomy in patients with primary liver cancer
Su Pengfei;,Wang Hao;,Zhu Bing;

..............page:194-195

Polyene phosphatidyl choline and silibinin in treatment of patients with nonalcoholic fatty liver
Liao Wenqiu;,Liu Xiaoye;,Zhang Li;

..............page:196-197

Progress in clinical diagnosis and treatment of patients with liver failure and hepatorenal syndrome
Li Jinge;,Nie Qinghe;

..............page:198-201

Diagnosis and treatment strategy of patients with liver failure and gastrointestinal bleeding
Chen Dongfeng;,Sun Wenjing;

..............page:202-205

Pathogenesis effects of transforming growth factor-β1 in hepatitis B virus infection-related liver diseases
Ma Yong;,Xu Chao;

..............page:206-209

fa ding ji liang dan wei fu hao de shu xie yao qiu

..............page:209-209

Hepatitis B viral gene mutation and disease progression in patients with hepatitis B virus infection
Chen Guofeng;,Li Fan;,Xu Dongping;

..............page:210-213

Progress in diagnosis and treatment of patients with portopulmonary hypertension
Cai Junjun;,Han Tao;

..............page:214-217

Advances of the researth of the value of antimitochondrial antibody in the diagnosis of primary biliary cirrhosis
Liu ran review;,Lu Lun-gen reviser;

..............page:218-220,221

Progress in microRNAs in the development of hepatocellular carcinoma
Li Jiansheng;,Pei Liling;,Ren Weihua;

..............page:221-224

yi xing gan yan bing du xiang guan gan ying hua de lin chuang zhen duan ping gu he kang bing du zhi liao de zong he guan li
ke ji bu shi er wu zhong da zhuan xiang lian he ke ti zu ;

..............page:225-234